Macquarie Group LTD Takeda Pharmaceutical CO LTD Transaction History

Macquarie Group LTD

  • $79.1 Billion
  • Q2 2025

A detailed history of Macquarie Group LTD transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Macquarie Group LTD holds 324 shares of TAK stock, worth $4,740. This represents 0.0% of its overall portfolio holdings.

Number of Shares
324
Previous 324 -0.0%
Holding current value
$4,740
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$13.0 - $15.08 $13.6 Million - $15.8 Million
-1,045,547 Reduced 99.97%
324 $4,000
Q2 2024

Aug 09, 2024
SELL
$12.6 - $13.67 $15.1 Million - $16.4 Million
-1,200,878 Reduced 53.45%
1,045,871 $13.5 Million
Q1 2024

May 14, 2024
SELL
$13.89 - $15.04 $2.77 Million - $3 Million
-199,193 Reduced 8.14%
2,246,749 $31.2 Million
Q4 2023

Feb 14, 2024
SELL
$13.36 - $15.43 $17.5 Million - $20.3 Million
-1,313,556 Reduced 34.94%
2,445,942 $34.9 Million
Q3 2023

Nov 14, 2023
SELL
$15.03 - $16.32 $1.07 Million - $1.16 Million
-71,257 Reduced 1.86%
3,759,498 $58.2 Million
Q2 2023

Aug 14, 2023
SELL
$15.57 - $17.11 $1.21 Million - $1.33 Million
-77,980 Reduced 2.0%
3,830,755 $60.2 Million
Q1 2023

May 15, 2023
BUY
$15.28 - $16.48 $1.11 Million - $1.2 Million
72,745 Added 1.9%
3,908,735 $64.4 Million
Q4 2022

Feb 21, 2023
SELL
$12.42 - $15.62 $1.96 Million - $2.47 Million
-158,054 Reduced 3.96%
3,835,990 $59.9 Million
Q3 2022

Nov 14, 2022
SELL
$12.8 - $28.65 $946,508 - $2.12 Million
-73,946 Reduced 1.82%
3,994,044 $51.8 Million
Q2 2022

Aug 15, 2022
SELL
$13.12 - $15.03 $2.01 Million - $2.31 Million
-153,391 Reduced 3.63%
4,067,990 $57.1 Million
Q1 2022

May 16, 2022
BUY
$13.54 - $15.35 $6.48 Million - $7.34 Million
478,256 Added 12.78%
4,221,381 $60.5 Million
Q4 2021

Feb 11, 2022
SELL
$13.17 - $16.4 $12.6 Million - $15.6 Million
-953,998 Reduced 20.31%
3,743,125 $51 Million
Q3 2021

Nov 12, 2021
SELL
$16.3 - $17.26 $710,500 - $752,346
-43,589 Reduced 0.92%
4,697,123 $76.9 Million
Q2 2021

Aug 13, 2021
BUY
$16.55 - $18.64 $7.27 Million - $8.19 Million
439,437 Added 10.22%
4,740,712 $79.8 Million
Q1 2021

May 14, 2021
BUY
$16.71 - $19.9 $609,915 - $726,350
36,500 Added 0.86%
4,301,275 $78.5 Million
Q4 2020

Feb 16, 2021
BUY
$15.39 - $18.97 $4.46 Million - $5.5 Million
290,037 Added 7.3%
4,264,775 $77.6 Million
Q3 2020

Nov 13, 2020
SELL
$17.1 - $19.19 $3.77 Million - $4.23 Million
-220,343 Reduced 5.25%
3,974,738 $70.9 Million
Q2 2020

Aug 11, 2020
SELL
$14.59 - $19.5 $12.3 Million - $16.5 Million
-844,716 Reduced 16.76%
4,195,081 $75.2 Million
Q1 2020

May 15, 2020
SELL
$13.02 - $20.31 $906,478 - $1.41 Million
-69,622 Reduced 1.36%
5,039,797 $76.5 Million
Q4 2019

Feb 14, 2020
SELL
$16.88 - $20.83 $3.23 Million - $3.98 Million
-191,217 Reduced 3.61%
5,109,419 $101 Million
Q3 2019

Nov 14, 2019
SELL
$16.15 - $17.99 $3.32 Million - $3.7 Million
-205,467 Reduced 3.73%
5,300,636 $91.2 Million
Q2 2019

Aug 14, 2019
BUY
$16.58 - $20.49 $12 Million - $14.9 Million
724,835 Added 15.16%
5,506,103 $97.5 Million
Q1 2019

May 15, 2019
BUY
$16.7 - $21.52 $79.8 Million - $103 Million
4,781,268 New
4,781,268 $97.4 Million

Others Institutions Holding TAK

# of Institutions
368
Shares Held
73.1M
Call Options Held
1.68M
Put Options Held
157K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $45.5B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email